Chemomab Therapeutics (CMMB) Free Cash Flow (2019 - 2023)
Chemomab Therapeutics (CMMB) free cash flow from Mar 31, 2019 to Mar 31, 2023. The TTM Chemomab Therapeutics (CMMB) free cash flow is -$24M. You can adjust inflation or export chart.
All data is split-adjusted. You can find the most accurate data from the reports on the SEC official website. We recommend verify information using official company filings before making investment decisions.
Annual Free Cash Flow
Quarterly Free Cash Flow
Chemomab Therapeutics (CMMB) Free Cash Flow CAGR table
| Period | CAGR |
|---|---|
| 1 Year TTM | +58.95% |
| 3 Years TTM | +11.08% |
| All Time TTM | +11.09% |
Annual Free Cash Flow change of Chemomab Therapeutics (CMMB)
| Year | Free Cash Flow | Change |
|---|---|---|
| 2025 | -$11M | -27.68% |
| 2024 | -$15M | -34.82% |
| 2023 | -$24M | +15.51% |
| 2022 | -$20M | +62.09% |
| 2021 | -$13M | -1.02% |
| 2020 | -$13M | -23.07% |
| 2019 | -$17M | +14.76% |
| 2018 | -$14M | +69.57% |
| 2017 | -$8.51M | +128.15% |
| 2016 | -$3.73M | N/A |